EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria

O J Balogun iD, R O Oladele, O O E Ajibola, A A Davies, T A Fashanu, A O Nwosu, B E Ekeng, J P Gangneux iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01533-24 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von O J Balogun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Lagos, Lagos, Nigeria. Hauptthemen laut MEDLINE: Immunoglobulin G, Antibodies, Fungal, Pulmonary Aspergillosis, Immunoglobulin M. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The detection of anti- Aspergillus antibodies is key for diagnosing chronic pulmonary aspergillosis (CPA). Available techniques are limited and pose a considerable challenge in resource-limited settings. The objective of this study was to evaluate the performance of the point-of-care test LDBio ICT IgG/IgM lateral flow assay (LDBio) versus that of the Bordier Elisa assay in a field study in Nigeria. Of the 97 serum samples tested in the CPA patient group, 71 tested positive by the LDBio assay with 69.4% sensitivity. In the non-CPA group, 286 of the 289 sera tested negative by the LDBio assay with 98.7% specificity. The Bordier test was positive for 97 of the 97 CPA serum samples tested, showing 100% sensitivity, significantly different from the LDBio test in detecting Aspergillus antibodies ( P < 0.0001). However, there was no significant difference in the specificity between the two tests ( P = 0.617). The results were in agreement for 353 of the 386 samples tested (91.5%), with a Cohen’s kappa coefficient of 0.75, indicating substantial agreement between the LDBio and Bordier test results. The LDBio lateral flow assay (LFA) test is a simple and rapid point-of-care test that can be used in field studies in which the Elisa test is not available. The lower sensitivity of the LDBio LFA in our field study could have been due to A. fumigatus being the species involved in only 50%–60% of cases in Nigeria, with A. flavus being more frequent than in Northern countries. IMPORTANCE Available techniques for the detection of Aspergillus IgG are limited and pose a considerable challenge in resource-limited settings in terms of affordability, skilled personnel, equipment, and a regular power supply. A point-of-care test would address most of these challenges. The LDBio lateral flow assay (LFA) test is a simple and rapid point-of-care test that can be used in field studies in which the Elisa test is not available. When combined with clinical features, the LFA can be used as a screening tool for chronic pulmonary aspergillosis in settings such as ours; however, a lower sensitivity was observed compared to the Elisa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GAntibodies, FungalPulmonary AspergillosisImmunoglobulin MHumansNigeriaEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityAspergillusChronic DiseasePoint-of-Care SystemsFemaleMaleMiddle AgedPoint-of-Care TestingAdult

Stichwörter der Autor:innen

Aspergillus flavusAspergillus fumigatusantibodieschronic pulmonary aspergillosispoint-of-care diagnosis

Substanzen

Immunoglobulin GAntibodies, FungalImmunoglobulin M

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Lagos, Lagos, Nigeria.
  • Medical Mycology Society of Nigeria, Lagos, Nigeria.
  • Department of Medical Microbiology and Parasitology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Department of Systems Engineering, Faculty of Engineering, University of Lagos, Lagos, Nigeria.
  • Department of Medical Microbiology and Parasitology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.
  • Department of Medical Microbiology and Parasitology, University of Calabar Teaching Hospital, Calabar, Nigeria.

ORCID-Profile: O J Balogun, J P Gangneux

Zitieren

APA

Balogun, O. J., Oladele, R. O., Ajibola, O. O. E., Davies, A. A., Fashanu, T. A., Nwosu, A. O., Ekeng, B. E., & Gangneux, J. P. (2025). Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01533-24

Vancouver

Balogun OJ, Oladele RO, Ajibola OOE, Davies AA, Fashanu TA, Nwosu AO, et al. Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01533-24

BibTeX
@article{Balogun2025,
  author = {Balogun, O J and Oladele, R O and Ajibola, O O E and Davies, A A and Fashanu, T A and Nwosu, A O and Ekeng, B E and Gangneux, J P},
  title = {Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01533-24}
}
Kostenlos starten →